Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Healthcare >

Cord Blood America Inc. (CBAI)

Add CBAI Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Myth, locksflooring
Search This Board:
Last Post: 11/21/2014 10:41:31 AM - Followers: 421 - Board type: Free - Posts Today: 0

Cord Blood America

(This "Intro Box" is NOT maintained by Cord Blood America and is intended solely as a quick information source on ihub.  For more detailed, up-to-date information on Cord Blood America,  please go the company website by clicking the link above..)

Company Summary

Cord Blood America, Inc.(CBAI), through its wholly owned subsidiary CorCell Companies, Inc., is engaged in the business of collecting, testing, processing and preserving umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy.

The umbilical cord which, at birth, traditionally has been thrown away, contains a rich store of stem cells. Cryogenically preserved umbilical cord stem cells have already been used to treat 75 major diseases, including leukemia, severe anemia, metabolic blood disorders and immune deficiencies. This list is guaranteed to grow as medical research learns more about the incredible healing power of stem cells.

There is uniformity in the belief that stem cells will play a key role in fighting disease as we move forward through this century. Some scientists are confident that stem cells will launch a new era in medicine, perhaps even curing some of our most intractable diseases.

Cord Blood America's Competitive Edge

CBAI offers extensive experience, with over 16 years in the cord blood banking industry, a proven processing model, technology and all the assistance our business to business clients need to grow their cord blood banking company without the additional cost of operating their own laboratory. CBAI is licensed in New Jersey, New York, California and Maryland and registered with the FDA.  They are also a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. 

Cord Blood America's state of the art laboratory is located minutes from McCarran International Airport in Las Vegas, NV; with approximately 3,300 inbound flights per week they are able to receive  customer samples 24/7/365.  Cord Blood America is a fully licensed cord blood bank that has processed more than 27,000 cord blood units since first opening in 1996. The 17,000-square-foot facility is equipped with the most advanced processing and storage technologies. The facility is under 24 hour surveillance with stringent restricted access protocols your client's cord blood unit will be kept at the correct temperature at all times thanks to our 24 hour monitoring system.

The Tissue Bank Director had more than 25 years of experience in the stem cell field.  A staff of highly experienced health professionals and technicians, working under the guidance and expertise of CBAI's Scientific/Medical Advisory Panel of industry leaders, offers both technical skill and unparalleled leadership. This unique combination of talents ensures that the laboratory remains on the cutting-edge of new cord blood advances, while guarenteeing the safety, integrity and viability of your customer's cord blood unit.

  News      Partnerships   Company History  Executive Team
Lab       SEC Filings    Videos                       Contacts

LAS VEGAS, May 15, 2012 /PRNewswire/ -- Cord Blood America, Inc. ( (OTC BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that, effective May 14, 2012, Matthew Schissler has resigned his position as Chairman, CEO, and Secretary, and as a Director of Cord Blood America.  Mr. Schissler is also no longer an officer or director with any of the Company's wholly owned subsidiaries. 

Joseph R. Vicente, who had been Chief Operating Officer and Vice President of the Company prior to May 15th, was appointed Chairman and President by the Board of Directors on May 15th.  Mr. Vicente joined the Company as a Director of Cord Blood America in April 2004.  He previously served as an independent consultant to companies, providing strategic consulting services on acquisitions, operational practices and efficiencies and sales management.  Mr. Vicente, who earned an MBA from the University of Tampa, has also held various executive positions with profit and loss responsibility for System One/TMP Worldwide, Inc.

The Board of Directors on May 15th also named Stephen Morgan as the Company's Vice President and Secretary.  He has served as General Counsel for the Company since August 2010 and will also remain in that role.  A graduate of Loyola Law School in Los Angeles, prior to working for the Company Mr. Morgan represented clients in a broad range of transactional and litigation matters working for law firms in the Los Angeles area.

Share Structure

Oct 2013, 890,000,000 
June 2013, 878,405,849 from page 24 

Transfer Agent:  Interwest Transfer Co.  (801) - 272-9294

AS:   895M
OS: 624,192,183 3-15-2013
OS:  249,999,364  12-31-2011 (as per 10K)
OS:  107,448,896  10-17-2011 (as per S1/A)
OS:  101,018,608  09-30-2011 (as per 10Q)
OS:   91,471,696  08-31-2011 (as per S-1/A)
OS:   81,762,984 08-29-2011 (as per SG-13)
OS:   70,895,400  06-30-2011 (as per Q2)
OS:   68,128,866  05-10-2011 (as per Q1) (after reverse split on 5/9/2011)
OS:  6,815,696,764 as of 03/13/11 (source: 03/13/11 10k -- 1.123B added in the last 4 mos)
OS:  5,692,564,026 as of 11/09/10 (source: 09/30/10 10Q -- 419M added in the last 3 mos)
OS:  5,273,093,131 as of 08/09/10 (source: 06/30/10 10Q -- 195M added in the last 5 mos)
OS:  5,078,132,870 as of 03/24/10 (source:03/31/10 10K -- 192M added in the last 3 mos)
OS:  4,886,468,478 as of Dec 31, 2009 (per 12/31/09 S-1  -- 318M added in the last 50days )
OS:  4,568,253,327 as of Nov 09, 2009 (per  11/03/09 10Q -- 1.95B added in the last 3 mos)
OS:  2,611,087,327 Aug 10, 2009 (per 8/14/09 10Q -- 1.03B added in the last 3 mos)
OS: 1,579,096,424 May 15, 2009 (per 10Q -- 636M added in the last 3 mos)
OS: 942,884,111 Feb 12, 2009 (per proxy statement -- 634M added in the last 3 mos) - Most of this has been sold through mm NITE & HDSN
OS: 309,474,243 Nov 10, 2008 (per 10Q -- 85M added in the last 4 mos)
OS: 224,699,718 Jul 08, 2008 (per 8/04/08 proxy statement)
OS: 225,154,440 Apr 07, 2008 (per 10k, --30M added in the last 4 months)
OS: 195,558,923 Dec 31, 2007 +21M)
OS: 174,048,335 Nov 11, 2007  +9M)
OS: 165,372,807 Sept 30, 2007 +6M)
OS: 159,055,819 Aug 14, 2007 +73M)
OS: 85,565,249 May 18, 2007  +37M)
OS: 49,118,075 Apr 02, 2007  +8M)
OS: 41,091,845 Nov 10, 2006


2011: $5,668,482
2010: $4,128,439
2009: $3,237,183
2008: $4,169,949
2007: $5,811,267
2006: $3,328,336
2005: $2,099,463


Cord Blood America, Inc.(CBAI), through its wholly owned subsidiary CorCell Companies, Inc., is engaged in the business of collecting, testing, processing and preserving umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy.

NEW CEO The entire interview is available at:

Cord Blood America, Inc "Companies"
- (13 locations)


September 30,2012,-249,999,364====Cash $369,186 Increase
June 30, 2012,-----249,999,364====Cash $332,928 Increase
March 31, 2012,----249,999,364====Cash $300,619 Increase

Assets Over $7million

2012: almost $6million
Share Outstanding= last known 643million with 890 a/s

Operating on its own cash= YES
Cash flow= 369,186

2011: $5,668,482
Operating on it own cash=NO

2010: $4,128,439
Shares outstanding 5.6 Billion shares
$66million market cap
Operating on it own cash= NO
Cash Flow= $236K
New Debt issued= YES

2009: $3,237,183==$30million market cap==

2008: $4,169,949
2007: $5,811,267
2006: $3,328,336
2005: $2,099,463

PR September 26, 2012 commented Joseph Vicente, President of Cord Blood America. "We are now cash flow positive so the announced approval to increase our authorized shares is primarily to fix legacy issues. Operating activities have already shown marked sequential and year over year improvement while reducing corporate costs creating an advantageous time to improve the capital structure and bring the Company to the next level while broadening its appeal to a wider audience of potential investors."

Nine-Months Ended September 30, 2012 Highlights

=====Revenue increase 18% to $4.64 million from $3.93 million in the year ago period.
=====Our cash position increased over 100% to $369,186.
=====Gross margin increased to 72.7% from 70.5% in the year ago period.
=====SG&A decreased 24% or $1.17 million to $3.64 million from $4.81 million.

For the second consecutive quarter, we demonstrated marked improvement in three key performance metrics; revenue growth, expense control and EBITDA. The result is that we have improved our cash position, while reducing the current liabilities without adding to the debt obligations of the Company. We continue to see consistent growth in the number of new customers added each quarter that will layer on top of our existing recurring revenue base. We expect our new customers to have an annual recurring duration of approximately eighteen years demonstrating the significant lifetime value of each new client," commented Joseph Vicente, President of Cord Blood America, Inc.

Share Structure

Projected SS:: Since September 30 2012 1.117 Billion shares have traded, based on statistics from the past 65% of shares trades would contribute to the outstanding = 726 Million shares outstanding as/of 03/13/2013 which

Finally, CBAI's President said that although the Company's financial situation has improved and the Company did not take any additional financing in Q2, it is not generating enough cash to pay off its entire debt balance. He urged shareholders to approve an increase in the number of authorized shares "as a means to retire out legacy debt and move forward."

Insurance Partners

Blue Cross Blue ShieldOur current healthcare partners listed below have negotiated a special program for our customers to save cord blood for their children, grandchildren, nieces, nephews, friends or other loved ones. To learn more about our insurance partners visit the CorCell® website at

Blue Cross of Idaho's

AmeriHealth Administrators
Asuris Northwest Health
Blue Cross Blue Shield of Kansas
Blue Cross Blue Shield of Northeastern Pennsylvania
Highmark Inc.
Highmark Blue Cross Blue Shield West Virginia
HMSA - Blue Cross Blue Shield of Hawaii
Horizon Blue Cross Blue shield of New Jersey
Independence Administrators
Independence Blue Cross
Keystone, Personal Choice (part of IBC, and BCBS of North Eastern PA)
LifeWise Assurance Company
LifeWise Health Plan of Oregon
LifeWise Health Plan of Washington
Premera Blue Cross
Permera Blue Cross Blue Shield of Alaska
Regence Blue Shield
Regence BlueCross Blue Shield of Oregon
Regence BlueCross Blue Shield of Utah
Regence BlueCross Blue


Joe has been a Director of Cord Blood America since April 2004. Additionally, he currently serves as the President. Prior to joining us Joe was an independent consultant where he provided strategic consulting services to organizations on acquisitions, operational practices and efficiencies, and sales management. He was a Senior Vice President at TMP Worldwide, Inc. where he held various positions with profit and loss responsibility.

Joe graduated from Bowling Green State University with a BSBA and from University of Tampa with an MBA.

Joseph Vicente Primarily involved in Mergers & Acquisitions, Corporate Governance
(702) 914-7250

The entire interview is available at:

Vice President & General Counsel

Stephen Morgan
Stephen Morgan currently serves as Vice President, General Counsel, and Secretary. He has been General Counsel of the Company since August 2010. Prior to his employment with the Company, Mr. Morgan worked for law firms in Los Angeles, California, representing clients in a broad range of transactional and litigation matters. Mr. Morgan earned his Bachelor of Science degree from the University of Minnesota and his Juris Doctor from Loyola Law School in Los Angeles, California.

(702) 914-7250

Tissue Bank Director

Dr. O'Neill has 25 years experience in the industry, processed more than 50,000 specimens and has published 78 papers. Educated at the University of Glasgow in Scotland, Dr. O'Neill came to the United States in 1979 to work for the Memorial Sloan-Kettering Cancer Center in New York. While continuing to work in the field his experience continued to grow as he also was a Professor at various prestigious universities including:

Cornell University school of Medicine, NY;
Columbia University, NY;
Visiting Professor at the Institute of Immunology in Munich

Dr. Geoffrey O'Neill
(702) 914-7250

more pictures :::

6 Month Chart



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CBAI News: Current Report Filing (8-k) 11/14/2014 09:01:00 AM
CBAI News: Cord Blood America Announces 2014 Third Quarter Financial Results 11/14/2014 08:45:00 AM
CBAI News: Quarterly Report (10-q) 11/14/2014 08:32:29 AM
CBAI News: Current Report Filing (8-k) 10/03/2014 08:30:16 AM
CBAI News: Cord Blood America, Inc. Announces Divestiture of Biocordcell Argentina, S.A. 10/03/2014 08:30:00 AM
#91448  Sticky Note holter, with Fife still holding almost 90 mill Myth 03/03/14 01:34:48 PM
#91905   I know this is doubtful BUT it would indebt2 11/21/14 10:41:31 AM
#91904   Ok you right my miswording :-) MsCoffeenut333 11/14/14 05:49:39 PM
#91903   Actually, the sale of the asset is mind1 11/14/14 05:44:28 PM
#91902   selling off assets to show revenue! MsCoffeenut333 11/14/14 05:31:29 PM
#91901   we go higher today. CBAI. dirkie 11/14/14 10:04:48 AM
#91900   not bad, CBAI. dirkie 11/14/14 10:03:47 AM
#91899   10Q is out skills3 11/14/14 08:37:02 AM
#91898   thanks for the information. i appreciate it. indebt2 11/12/14 02:25:39 PM
#91897   Nov 28th is when the trial date will mind1 11/12/14 02:21:01 PM
#91896   if I remember right, someone from this message indebt2 11/12/14 02:17:38 PM
#91895   CBAI is in a colossal stalemate...only the 10-20% Myth 11/12/14 12:21:02 PM
#91894   thank you for your response tonym TONYM 11/10/14 06:58:44 PM
#91892   Only 784m shs (6%)were attributable to short volume. mind1 11/10/14 05:40:47 PM
#91891   Bam!! Beautiful close! It's just a matter of GreenThumb Investor 11/10/14 04:30:25 PM
#91890   Also, of the 13.6 mill shares a block mind1 11/10/14 04:07:05 PM
#91889   yess 0.0024---volume 13675131 !! dirkie 11/10/14 04:03:00 PM
#91888   Looks to me a settlement might be s mind1 11/10/14 04:00:14 PM
#91887   the question here is can we win it! boardbrain1 11/10/14 02:03:06 PM
#91886   Looks like they get a bench trial and diannedawn 11/10/14 12:14:51 PM
#91885   I have no idea thrill97 11/09/14 07:21:25 PM
#91884   how close to a resolution is cbai and TONYM 11/09/14 10:47:00 AM
#91883   Ok thanks for that. I wasn't sure exactly thrill97 11/09/14 09:32:55 AM
#91882   They are a pink SEC filer, which means Myth 11/08/14 09:03:43 AM
#91881   Then how did Yahoo know? mind1 11/08/14 05:43:10 AM
#91880   Maybe St. George covering their short sales. holter 11/08/14 02:48:08 AM
#91879   It's a pinky. They don't file everything. In thrill97 11/07/14 05:29:24 PM
#91878   Just a thought Aug showed 41 mill, however mind1 11/07/14 02:48:01 PM
#91877   just trying to figure out what I was boardbrain1 11/07/14 02:43:48 PM
#91876   If the info is correct , I would mind1 11/07/14 02:20:10 PM
#91875   Do not know-- this was your post-- Unless mind1 11/07/14 02:15:21 PM
#91874   see Post # 91772 on Aug 25 2014 boardbrain1 11/07/14 01:58:06 PM
#91873   This represents Total Insider Shares Held and 5% mind1 11/07/14 01:14:48 PM
#91872   Insider Purchase Transaction last 6 Months 113.96M?? boardbrain1 11/07/14 09:16:23 AM
#91871   it appears that the sells are being washed Roy London 10/29/14 03:42:03 PM
#91870   mind 1 indebt2 10/28/14 09:57:53 PM
#91869   11/28/2014 is when the court sets the trial date. mind1 10/28/14 12:54:17 PM
#91868   does anyone know when this is suppose to indebt2 10/28/14 12:44:45 PM
#91867   Looking for lower. If the 19$ start to Roy London 10/27/14 09:56:13 AM
#91866   I got 1.5 Mil at the Bid last thrill97 10/26/14 09:46:17 PM
#91865   didn't say it was a bad thing.....not at all.. Myth 10/26/14 06:51:05 PM
#91864   who as an insider has any shares??? surely TONYM 10/26/14 06:44:23 PM
#91863   That could be, but the shares are being mind1 10/26/14 06:17:51 PM
#91862   As far as I know, 11/28/2014 is when mind1 10/26/14 06:15:30 PM
#91861   During the year ended December 31, 2013, the Myth 10/26/14 06:13:13 PM
#91860   The indicators show selling the last two days Roy London 10/26/14 06:09:46 PM
#91859   I do not see this as the case. mind1 10/26/14 05:22:01 PM
#91858   This thing has been getting a lot of Roy London 10/26/14 03:33:08 PM
#91857   Only if he falls below 5%....imo he could Myth 10/23/14 02:17:54 PM
#91856   with fife holding 89M, if he was to boardbrain1 10/23/14 09:08:45 AM
#91854  Restored Don't know if you are being sarcastic. All mind1 10/21/14 07:58:58 AM